Try our Advanced Search for more refined results
MEDEVA PHARMA SUISSE A.G. et al v. ROXANE LABORATORIES, INC.
Case Number:
3:07-cv-05165
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
February 23, 2011
Roxane Agrees To Delay Launch Of Generic Asacol
A federal judge on Tuesday put a patent infringement suit over inflammatory bowel disorder drug Asacol on hold, following defendant generic-drug maker Roxane Laboratories Inc.'s agreement to delay the launch of a generic version of the drug until September.
-
January 31, 2011
Judge Sanctions Roxane In Asacol Patent Suit
A federal judge has ruled that Roxane Laboratories Inc. must pay some of the expert and attorneys' fees for the plaintiffs in a patent dispute over inflammatory bowel drug Asacol as punishment for concealing a batch of its generic version.
-
January 24, 2011
Protected Docs Still In Play In Generic Asacol Spat
A federal judge has overturned the rejection of Medeva Pharma Suisse AG and Warner Chilcott Pharmaceuticals Inc.'s bid to force generic-drug maker Roxane Laboratories Inc. to disclose allegedly confidential documents in their dispute over inflammatory bowel disorder drug Asacol.
-
March 12, 2010
Roxane Agrees To Hold Off On Generic Asacol
Roxane Laboratories Inc. has agreed to delay its launch of a generic version of inflammatory bowel drug Asacol until as late as November as part of a discovery agreement in a patent infringement suit brought by Procter & Gamble Pharmaceuticals Inc. and Medeva Pharma Suisse AG.